cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SINGAPORE, Nov. 11, 2020 /PRNewswire-AsiaNet/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass(TM) SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA) Singapore on 8th May 2020, CE-IVD mark...
Authors: LATEST ASIANET NEWS RELEASES